Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 Next >
Medicare details plan to cover Alzheimer's treatments
Tags Health care industry Alzheimer's disease Biotechnology
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Eli Lilly and Co Business Eisai Co Ltd
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Policy Biotech and Pharmaceuticals Business
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags US: News Business News Health & Science
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Biogen Inc Business News US: News
From CNBC.com News
March 2023 Miscellany
Tags GlaxoSmithKline (GSK) Eisai (ESALY) Alzheimer's Disease
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags Cassava Sciences (SAVA) Parkinson's Disease Doc Gumshoe
From Stock Gumshoe
Relevant Updates – December 2022
Tags influenza Moderna Therapeutics (MRNA) Eisai (ESALY)
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags Market News MOR Biotech
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Self/improvement Twitter (delisted) Health
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Cannabis medical cannabis Market News
From Benzinga
Odd & Ends – October 2022
Tags Roche (RHHBF RHHBY) Doc Gumshoe Eli Lilly (LLY)
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags ESALY ACIU LGVN
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Aduhelm BIIB ESALY
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags inflammation Rheumatoid Arthritis Doc Gumshoe
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Dr Pat Alagia Events, Media & Communications Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags Penny Stocks General CGTX
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags Alzheimer's Disease Doc Gumshoe INmune Bio (INMB)
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags ABBV General Small Cap
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Alzheimer's Disease TauRX Pharmaceuticals Guest Articles
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags Benzinga Biotech Health Care
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags inflammation Eisai (ESALY) BACE Inhibitors
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Market News FDA Benzinga
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags Movers General SAVA
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags General LGVN Phase 2 Trial
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Market News Biotech Benzinga
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags Phase 1 Trial General Alzheimer’s
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags General ESALY BIIB
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Phase 3 Trial General Benzinga
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Tickers PRTA
Tags News Briefs Biotech
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.